NCT01039207 2017-09-07Rilotumumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerGOG FoundationPhase 2 Completed31 enrolled 12 charts